Post-hoc Analysis of the Effects of Dose Reductions of Concomitant Clobazam in a Phase 3, Open-Label Study of Cenobamate for the Treatment of Uncontrolled Focal Seizures
Publication/Presentation Date
4-2021
Volume
96
Issue
15
First Page
1851
Last Page
1851
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS